Publicaciones en colaboración con investigadores/as de Hospital Universitario de Salamanca (9)

2022

  1. Endoglin and Other Angiogenesis Markers in Recurrent Varicose Veins

    Journal of Personalized Medicine, Vol. 12, Núm. 4

  2. Mesenchymal Stromal Cells Combined With Elastin-Like Recombinamers Increase Angiogenesis In Vivo After Hindlimb Ischemia

    Frontiers in Bioengineering and Biotechnology, Vol. 10

2016

  1. Mechanisms of triple whammy acute kidney injury

    Pharmacology and Therapeutics, Vol. 167, pp. 132-145

2015

  1. Heterozygous disruption of activin receptor-like kinase 1 is associated with increased arterial pressure in mice

    DMM Disease Models and Mechanisms, Vol. 8, Núm. 11, pp. 1427-1439

2013

  1. Alteration in Endoglin-Related Angiogenesis in Refractory Cytopenia with Multilineage Dysplasia

    PLoS ONE, Vol. 8, Núm. 1

2012

  1. C3G transgenic mouse models with specific expression in platelets reveal a new role for C3G in platelet clotting through its GEF activity

    Biochimica et Biophysica Acta - Molecular Cell Research, Vol. 1823, Núm. 8, pp. 1366-1377

2008

  1. Identification of serum endoglin as a novel prognostic marker after acute myocardial infarction: Molecular Diagnosis

    Journal of Cellular and Molecular Medicine, Vol. 12, Núm. 3, pp. 955-961

  2. The mitogen-activated protein kinase Erk5 mediates human mesangial cell activation

    Nephrology Dialysis Transplantation, Vol. 23, Núm. 11, pp. 3403-3411

2007

  1. Human recombinant erythropoietic agents do not induce changes in circulating levels of endoglin and vascular endothelial growth factor in anemic cancer patients

    Cancer Letters, Vol. 255, Núm. 1, pp. 71-76